Showing 8191-8200 of 8908 results for "".
- ALASTIN™ Skincare, Inc. Announces New Scientific Advisory Councilhttps://practicaldermatology.com/news/alastin-skincare-inc-announces-new-scientific-advisory-council/2458667/ALASTIN™ Skincare, Inc., announced its new eight-person Scientific Advisory Council. The Council includes: · Vivian Bucay, M.D., Dermatologist, B
- Galderma Launches Three New DTC Campaignshttps://practicaldermatology.com/news/galderma-launches-three-new-dtc-campaigns/2458673/Galderma is rolling out three new direct-to-consumer creative campaigns designed to educate consumers and support Dysport® and Restylane® Silk. The campaigns, which feature unretouched photography, will be supported by significant print,
- Dermwire's Inside Scoop on Hottest Expected AAD2016 Launcheshttps://practicaldermatology.com/news/dermwires-inside-scoop-on-hottest-expected-aad2016-launches/2458670/The American Academy of Dermatology (AAD)’s annual meeting is the place for skin care companies looking to launch the latest – and hopefully greatest --- innovations or iterations in skin care products and technologies. And the
- Cipher Launches Bionect Foamhttps://practicaldermatology.com/news/cipher-launches-bionect-foam/2458678/Cipher Pharmaceuticals’ prescription topical Bionect® is now available in the US in a lightweight foam preparation that holds its shape until application. The company says the for
- FDA Approves Allergan's Aczone Gel, 7.5% for Acne Vulgarishttps://practicaldermatology.com/news/fda-approves-allergans-aczone-gel-75-for-acne-vulgaris/2458681/The FDA approved Allergn’s Aczone (dapsone) Gel, 7.5%, a new prescription topical treatment for acne in patients 12 years of age and older. Aczone Gel, 7.5% delivers proven efficacy to treat both inflammatory and non-inflammatory acne, with a new concentration of dapsone in just once-a-day
- Neutrogena® Launches First-Ever Global Beauty Campaignhttps://practicaldermatology.com/news/neutrogena-launches-first-ever-global-beauty-campaign/2458684/Neutrogena® is set to debut their first-ever global campaign: “Neutrogena. See What’s Possible.™” A commercial voiced by Brand Ambassador and creative consultant Kerry Washington will fe
- Botox Helps Fuel Allergan's “Better-Than-Expected” Q4 Earningshttps://practicaldermatology.com/news/botox-helps-fuel-allergans-better-than-expected-q4-earnings/2458687/Allergan is reporting “better-than-expected” fourth-quarter earnings, largely fueled by Botox. The company saw a 74 percent increase in Q4 net revenue to $4.2 Billion for Q4 2015, topping the nearly $4.18 billion consensus estimate of S&a
- Good Deal: DS Healthcare Acquires Radiancy, Neovahttps://practicaldermatology.com/news/good-deal-ds-healthcare-acquires-radiancy-neova/2458692/DS Healthcare Group, Inc. will acquire Radiancy, Inc., and Neova® from PhotoMedex, Inc. The board of directors of both companies have voted unanimously in favor o
- Sweet Acne Cure: Kanuka Honey from New Zealand May Eradicate Acnehttps://practicaldermatology.com/news/sweet-acne-cure-kanuka-honey-from-new-zealand-may-eradicate-acne/2458693/Kanuka honey may help out the brakes on acne, new research suggests. In the study of Honevo®, developed by New Zealand pharmaceutical company HoneyLab, twice as many participants had an imp
- New Initiative Seeks To Raise Biosimilar Awareness, Accesshttps://practicaldermatology.com/news/new-initiative-to-raise-biosimilar-awareness-access/2458689/The Biosimilars Forum is launching a new biosimilars education initiative. The Partnership for Biosimilars Education and Access will focus on raising awareness and encouraging access to biosimilars in the United States. The Forum